Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
Sasson SC; Zaunders JJ; Nahar K; Munier CML; Fairfax BP; Olsson-Brown A; Jolly C; Read SA; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Payne MJ; Cheung VTF; Gupta T; Klenerman P; Long GV; Brain O; Menzies AM; Kelleher AD, 2020, 'Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis', Clinical and Experimental Immunology, vol. 202, pp. 335 - 352, http://dx.doi.org/10.1111/cei.13502
Cheung VTF; Gupta T; Olsson-Brown A; Subramanian S; Sasson SC; Heseltine J; Fryer E; Collantes E; Sacco JJ; Pirmohamed M; Simmons A; Klenerman P; Tuthill M; Protheroe AS; Chitnis M; Fairfax BP; Payne MJ; Middleton MR; Brain O, 2020, 'Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?', British Journal of Cancer, vol. 123, pp. 207 - 215, http://dx.doi.org/10.1038/s41416-020-0882-y
Sasson SC; Gordon CL; Christo SN; Klenerman P; Mackay LK, 2020, 'Local heroes or villains: tissue-resident memory T cells in human health and disease', Cellular and Molecular Immunology, vol. 17, pp. 113 - 122, http://dx.doi.org/10.1038/s41423-019-0359-1
Sasson SC; Corbett A; McLachlan AJ; Chen R; Adelstein SA; Riminton S; Limaye S, 2019, 'Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: A case series and review of the literature', Journal of Medical Case Reports, vol. 13, http://dx.doi.org/10.1186/s13256-019-2285-3
Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, vol. 38, pp. 159 - 162, http://dx.doi.org/10.1007/s10875-018-0477-z
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S, 2017, 'Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: Two case reports and a review of the literature', Journal of Medical Case Reports, vol. 11, http://dx.doi.org/10.1186/s13256-017-1453-6
Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals', Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 328 - 337, http://dx.doi.org/10.1097/QAI.0000000000001381
Sasson SC; Davies S; Chan R; Davies L; Garsia R, 2016, 'Cerebral toxoplasmosis in a patient with myasthenia gravis and thymoma with immunodeficiency/Good's syndrome: A case report', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1801-y
Anderson S; Sasson SC; Lee FJ; Cooper W; Larsen S; Garsia R, 2016, 'Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: A case report', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1378-5
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, vol. 47, pp. 564 - 569, http://dx.doi.org/10.1097/PAT.0000000000000316
Sasson SC; Smith SA; Qiu MR; Stone ECA; Sewell WA, 2015, 'Monoclonal precursor T-cell infiltrate in recurrent thymoma: a case report', Pathology, vol. 47, pp. 375 - 377, http://dx.doi.org/10.1097/PAT.0000000000000257
Sasson S; Smith S; Sewell WA; Morey A; Danta M; Emmett L; Kelleher AD; Fay K; Phan T, 2014, 'MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY', INTERNAL MEDICINE JOURNAL, vol. 44, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sasson SC; Kelleher AD, 2014, 'Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?', Clinical and Translational Immunology, vol. 3, http://dx.doi.org/10.1038/cti.2014.12
Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, vol. 13, pp. 396 - 396, http://dx.doi.org/10.1186/1471-2334-13-396
Sasson SC; Zaunders J; Seddiki N; Mcbride K; Koelsch KK; Merlin KM; Smith DE; Cooper DA; Kelleher AD; Bailey MR, 2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection', PLoS One, vol. 7, pp. e31148, http://dx.doi.org/10.1371/journal.pone.0031148
Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, vol. 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630
Sasson SC; Zaunders J; Kelleher AD, 2006, 'The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostatis and the challenges facing its utilization as a novel therapy. 2006;7:1571-1582.', Current Drug Targets, vol. 7, pp. 1571 - 1582, http://dx.doi.org/10.2174/138945006779025365
Zaunders J; Ip S; Munier CM; Munier M; Kaufmann D; Suzuki K; Brereton C; Seddiki N; Sasson SC; Koelsch KK; Landay A; Grey PA; Finlayson R; Kaldor JM; Rosenberg E; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD, 2006, 'Infection of CD127(+) (Interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection', Journal of Virology, vol. 80, pp. 10162 - 10172, http://dx.doi.org/10.1128/JVI.00249-06
Sasson SC; Zaunders J; Zanetti G; King E; Merlin K; Smith DE; Stanley K; Cooper DA; Kelleher AD, 2006, 'Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection', Journal of Infectious Diseases, vol. 193, pp. 505 - 514, http://dx.doi.org/10.1086/499309
Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Solomon MJ; Selby W; Alexander S; Nanan R; Kelleher AD; Fazekas de St Groth B, 2006, 'Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells', Journal of Experimental Medicine, vol. 203, pp. 1693 - 1700, http://dx.doi.org/10.1084/jem.20060468
Fazekos de St Groth B; Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Nanan R; Kelleher AD, 2006, 'Expression of IL-2 and IL-7 receptors discriminates between human regulatory and activated T-cells within CD45RA and CD45RO compartments', Clinical Immunology, vol. 119, pp. S7 - S7, http://dx.doi.org/10.1016/j.clim.2006.04.010
Sasson SC; Kelleher AD; Cooper DA, 2005, 'The modern ART of HIV infection management: Towards a tailored approach to maximize CD4 T cell reconstitution', Clinical Infectious Diseases, vol. 41, pp. 373 - 375, http://dx.doi.org/10.1086/431489
Cheung VT; Gupta T; Olsson-Brown AC; Subramanian S; Sasson SC; Heseltine J; Fryer E; Collantes-Bellido E; Sacco JJ; Pirmohamed M; Simmons A; Klenerman P; Fairfax BP; Payne MJ; Middleton MR; Brain O, 2020, 'IMMUNE CHECKPOINT INHIBITOR-RELATED COLITIS ASSESSMENT AND PROGNOSIS: CAN UCEIS, MAYO AND NANCY INDEX SCORING POINT THE WAY?', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Austin, TX, Vol. 158, pp. S535 - S536, presented at Crohn's and Colitis Congress, Austin, TX, 23 January 2020 - 25 January 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349501585&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Cheung VTF; Gupta T; Olsson-Brown A; Subramanian S; Sasson SC; Heseltine J; Fryer E; Collantes E; Sacco JJ; Pirmohamed M; Simmons A; Klenerman P; Fairfax BP; Payne MJ; Middleton MR; Brain O, 2020, 'Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 14, pp. S286 - S288, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518803401171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sasson SC; Cheung VTF; Gupta T; Zaunders JJ; Nahar K; Munier CM-L; Olsson-Brown A; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Long GV; Menzies AM; Kelleher A; Payne M; Fairfax B; Middleton MR; Klenerman P; Brain O, 2019, 'Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, Vol. 30, pp. 530 - 530, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 September 2019 - 01 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sasson SC; Zaunders J; Nahar K; Munier C; Read SA; Ahlensteil G; Palendira U; Scolyer RA; Carlino M; Long GV; Menzies AM; Kelleher AD, 2019, 'Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Vienna, AUSTRIA, Vol. 110, pp. S21 - S22, presented at 6tth International Cancer Immunotherapy Conference in Europe (ITOC), Vienna, AUSTRIA, 11 April 2019 - 13 April 2019, http://dx.doi.org/10.1016/j.ejca.2019.01.072
Sasson SC; McGill K; Weinholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Sasson SC; Davies S; Chan R; Davies L; Garsia R, 2015, 'IN GOOD CONSCIENCE', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 28 - 28, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1